Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications
Krishnamoorthy, Jothi, Rajesh, Kamindla, Mirzajani, Farzaneh, Kesoglidou, Polixenia, Papadakis, Andreas, Koromilas, Antonis E.
Published in Cell cycle (Georgetown, Tex.) (01.03.2014)
Published in Cell cycle (Georgetown, Tex.) (01.03.2014)
Get full text
Journal Article
The eIF2α serine 51 phosphorylation-ATF4 arm promotes HIPPO signaling and cell death under oxidative stress
Rajesh, Kamindla, Krishnamoorthy, Jothilatha, Gupta, Jyotsana, Kazimierczak, Urszula, Papadakis, Andreas I, Deng, Zhilin, Wang, Shuo, Kuninaka, Shinji, Koromilas, Antonis E
Published in Oncotarget (09.08.2016)
Published in Oncotarget (09.08.2016)
Get full text
Journal Article
eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies
Rajesh, Kamindla, Papadakis, Andreas I, Kazimierczak, Urszula, Peidis, Philippos, Wang, Shuo, Ferbeyre, Gerardo, Kaufman, Randal J, Koromilas, Antonis E
Published in Aging (Albany, NY.) (01.12.2013)
Published in Aging (Albany, NY.) (01.12.2013)
Get full text
Journal Article
HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2
Peidis, Philippos, Papadakis, Andreas I, Rajesh, Kamindla, Koromilas, Antonis E
Published in Aging (Albany, NY.) (01.10.2010)
Published in Aging (Albany, NY.) (01.10.2010)
Get full text
Journal Article
Abstract C51: eIF2alpha phosphorylation determines cell susceptibility to oxidative stress via Akt activation
Koromilas, Antonis E., Kamindla, Rajesh, Papadakis, Andreas I., Kazimierczak, Urszula, Peidis, Philippos, Wang, Shuo, Tenkerian, Clara, Krishnamoorthy, Jothi-Latha, Hatzoglou, Maria, Haj, Fawaz G., Ferbeyre, Gerardo, Kaufman, Randal J.
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article